This inventor holds 1 USPTO granted patent. Top assignee: Shandong University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Anran Sheng: Innovator in Low Molecular Weight Heparin Detection
Introduction
Anran Sheng is a notable inventor based in Jinan, China. He has made significant contributions to the field of biochemistry, particularly in the detection of low molecular weight heparin degradation products. His innovative approach utilizes advanced chromatography techniques to enhance the accuracy of quantitative analysis in this area.
Latest Patents
Anran Sheng holds a patent for a "Detection method for low molecular weight heparin complete degradation products using hydrophilic interaction chromatography and multiple reaction monitoring tandem mass spectrometry." This method involves identifying the original reducing end and non-reducing end of enoxaparin sodium by reducing the reducing end and performing hydrolysis with hydrogen peroxide. The technique allows for quantitative analysis of all component units, focusing on low-content special structures and characterizing low molecular weight heparin.
Career Highlights
Anran Sheng is affiliated with Shandong University, where he conducts research and develops innovative methods in his field. His work has garnered attention for its potential applications in medical diagnostics and therapeutic monitoring.
Collaborations
Anran collaborates with talented colleagues, including Xinyue Liu and Lianli Chi, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work in the scientific community.
Conclusion
Anran Sheng's contributions to the detection of low molecular weight heparin degradation products exemplify the importance of innovation in biochemistry. His patented methods pave the way for advancements in medical diagnostics and therapeutic applications.